E Fund Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$809K Sell
7,825
-981
-11% -$87.6K 0.02% 209
2026
Q1
$632K Buy
+8,806
New +$678K 0.02% 234
2025
Q2
$496K Sell
7,185
-537
-7% -$35.2K 0.02% 228
2025
Q1
$523K Sell
7,722
-1,668
-18% -$99.8K 0.03% 221
2024
Q4
$422K Buy
9,390
+4,392
+88% +$246K 0.02% 250
2024
Q3
$314K Buy
4,998
+276
+6% +$16.1K 0.02% 254
2024
Q2
$279K Buy
4,722
+467
+11% +$29.2K 0.02% 242
2024
Q1
$339K Buy
4,255
+597
+16% +$45.6K 0.02% 258
2023
Q4
$289K Buy
3,658
+313
+9% +$22.3K 0.02% 234
2023
Q3
$234K Sell
3,345
-100
-3% -$7.09K 0.02% 231
2023
Q2
$238K Sell
3,445
-194
-5% -$13.8K 0.02% 258
2023
Q1
$270K Buy
3,639
+60
+2% +$5.03K 0.02% 247
2022
Q4
$334K Sell
3,579
-355
-9% -$34.3K 0.03% 213
2022
Q3
$375K Buy
3,934
+270
+7% +$26.7K 0.03% 198
2022
Q2
$340K Buy
3,664
+50
+1% +$4.88K 0.03% 214
2022
Q1
$366K Sell
3,614
-543
-13% -$57K 0.01% 160
2021
Q4
$429K Sell
4,157
-259
-6% -$23.9K 0.02% 176
2021
Q3
$375K Buy
+4,416
New +$370K 0.02% 169
2021
Q1
$271K Buy
+3,607
New +$263K 0.02% 188

Other funds holding CVS

E Fund Management's CVS Position: Q2 2026 in Review

E Fund Management reduced its CVS Health (CVS) stake by 11% in Q2 2026, selling an estimated $87.6K and leaving 7,825 shares worth $809K. The position accounts for 0.02% of the portfolio, ranked #209.

E Fund Management first reported a position in CVS in Q1 2021 and has held it in 19 quarters since. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • E Fund Management held 7,825 shares of CVS Health worth $809K as of Q2 2026.
  • E Fund Management sold 981 CVS Health shares in Q2 2026, an estimated $87.6K.
  • CVS Health made up 0.02% of E Fund Management's portfolio in Q2 2026, its #209 holding.
  • E Fund Management first reported a position in CVS Health in Q1 2021 and has held it in 19 quarters since.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on E Fund Management's 13F filing for Q2 2026, filed 11 Aug 2026.